Search

Lonza Group AG

Open

SectorHealthcare

652.79 0.65

Overview

Share price change

24h

Current

Min

643.4

Max

652.6

Key metrics

By Trading Economics

Income

88M

571M

Sales

419M

3.4B

P/E

Sector Avg

42.068

50.373

EPS

8.45

Dividend yield

0.79

Profit margin

16.924

Employees

20,141

EBITDA

321M

1.1B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+7.99% upside

Dividends

By Acuity

Dividend yield

Sector Avg

0.79%

2.12%

Next Earnings

27 sty 2027

Market Stats

By TradingEconomics

Market Cap

4.9B

44B

Previous open

652.14

Previous close

652.79

Lonza Group AG Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

2 lis 2026, 23:56 UTC

Social Media
News

Roku, Inc. reported Q3 2026 earnings per share of $1.20 and revenue of $1.5 billion, exceeding analyst estimates, but did not provide forward guidance.

2 lis 2026, 23:51 UTC

Social Media
News
Correlated Moves

Ichor Holdings reported Q3 2026 adjusted EPS of $0.63, above the $0.45 consensus, and provided positive Q4 guidance of $0.65 to $0.75.

2 lis 2026, 23:41 UTC

News

Stifel Financial Corp. declares a quarterly cash dividend of $0.34 per share, payable December 15, 2026, to shareholders of record as of December 1, 2026.

2 lis 2026, 23:41 UTC

News

Rivian Automotive, Inc. is seeing a modest increase in after-market trading, supported by higher overall market trends and a trading volume of 64.3 million shares.

2 lis 2026, 23:41 UTC

News

Camping World Holdings Inc reported a Q3 net loss of $320.1 million and missed adjusted EPS expectations, prompting a sharp decline in after-market trading.

2 lis 2026, 23:31 UTC

News

EverQuote, Inc. reported Q3 revenue of $218.1 million, exceeding estimates, and expects Q4 revenue between $213 million and $223 million.

2 lis 2026, 23:26 UTC

News

Amgen Inc. will release its third quarter 2026 financial results on November 3, 2026, after U.S. markets close, followed by a conference call.

2 lis 2026, 23:21 UTC

News

Capital Southwest Corporation reported Q2 pre-tax net investment income of $37.2 million and net asset value per share of $16.64, despite $13.4 million in investment losses.

2 lis 2026, 23:21 UTC

Social Media
News
Correlated Moves

Intel Corp is trading higher in after-market hours following a quarterly report that included a downward guidance adjustment.

2 lis 2026, 23:21 UTC

Social Media
News

Oracle Corporation plans to raise $20 billion through stock and bond offerings to finance its artificial intelligence infrastructure expansion, according to regulatory filings.

2 lis 2026, 23:21 UTC

News

Celsius Holdings faces a class action lawsuit from Pomerantz LLP over alleged misrepresentation of safety regarding its Alani Nu energy drinks.

2 lis 2026, 23:21 UTC

News
Event

Douglas Dynamics reports record Q3 results with net sales up 35% to $218.0M and net income rising 166% to $21.2M, despite missing revenue expectations.

2 lis 2026, 23:21 UTC

Correlated Moves
Social Media
News

Lumentum Holdings Inc. shares rose during after-market hours, following Fabrinet's strong fiscal Q1 results and positive revenue guidance for Q2.

2 lis 2026, 23:21 UTC

News

Keysight Technologies appoints Jason Kary as Chief Financial Officer, effective December 18, 2026, while maintaining its outlook for Q4 fiscal 2026.

2 lis 2026, 23:16 UTC

News

Leidos Holdings plans to enhance its supply chain for long-range cruise missiles, with initial deliveries expected in 2027 under a framework agreement with the Department of War.

2 lis 2026, 23:16 UTC

News

Jazz Pharmaceuticals reports record Q3 revenues of $1.2 billion and raises full-year guidance to $4.775 billion to $4.850 billion despite a net loss of $483.4 million.

2 lis 2026, 23:16 UTC

News

Thermo Fisher Scientific Inc. has a market capitalization of $262.95 billion, with shares advancing in after-market trading following earlier declines.

2 lis 2026, 23:16 UTC

News

Enovix Corporation filed a registration statement with the SEC to offer up to $500 million in mixed securities to enhance financial flexibility for growth initiatives.

2 lis 2026, 23:12 UTC

Social Media
Correlated Moves
News

Advanced Micro Devices, Inc. is advancing in after-market trading, influenced by Aehr Test Systems' record revenue and raised outlook for fiscal 2027.

2 lis 2026, 23:11 UTC

News

HealthStream, Inc. reported Q3 revenues of $83.3 million and EPS of $0.18, raising full-year 2026 revenue guidance to $331 million to $333 million.

2 lis 2026, 23:06 UTC

News

Public Service Enterprise Group shares traded modestly lower in after-market hours, retracing from earlier gains amid a day of unusual volatility.

2 lis 2026, 23:06 UTC

News

Replimune Group, Inc. will meet with Cantor on November 4 in New York and November 5 in Boston to discuss its strategic direction.

2 lis 2026, 23:06 UTC

Social Media
News

Match Group reported Q3 revenue of $891.2 million, below the $892.5 million estimate, and guided for Q4 revenue of $865 million to $875 million.

2 lis 2026, 23:06 UTC

News

UBS maintains Buy rating on Arch Capital Group Ltd. and raises price target to $125 in a report published today.

2 lis 2026, 23:06 UTC

News

AbbVie Inc. gains after director Jennifer L. Davis resigns to become CEO at Align Technology; UBS raises price target to $295 while maintaining Neutral rating.

2 lis 2026, 23:06 UTC

Social Media
News

Diamondback Energy reported strong third-quarter results, with adjusted EPS of $5.86 and revenues of $5.43 billion, while raising its base dividend to $1.18 per share.

2 lis 2026, 23:06 UTC

Social Media
News

Salesforce, Inc. has signed a definitive agreement to acquire Cresta, enhancing its Service Cloud with voice-based AI agents for customer service operations.

2 lis 2026, 23:06 UTC

News

UBS maintains Neutral rating on American Express and raises price target to $346, following the company's increased third-quarter net income and raised earnings guidance.

2 lis 2026, 23:06 UTC

Social Media
News

Marvell Technology, Inc. is trading higher in after-market hours following its $115 billion acquisition of Lumentum Holdings, aimed at enhancing AI growth.

2 lis 2026, 23:02 UTC

News

Regeneron Pharmaceuticals plans to webcast management participation at upcoming investor conferences, including Jefferies on November 17 and Evercore on December 1, 2026.

Lonza Group AG Forecast

Price Target

By TipRanks

7.99% upside

12 Months Forecast

Average 700 CHF  7.99%

High 770 CHF

Low 650 CHF

Based on 3 Wall Street analysts offering 12 month price targets forLonza Group AG - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Lonza Group AG

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing. The Small Molecules segment operates as an integrated development and manufacturing service provider for small molecule drug substances and their intermediates. This segment also supports customers across various aspects of design, development, and manufacturing, including particle engineering and drug product packaging. The Cell & Gene segment develops technologies and platforms that industrialize the manufacturing processes and production of cell and gene therapies; offers contract development and manufacturing services, and regulatory support for a range of allogeneic and autologous cell therapies, and exosome-based therapies, as well as viral vector gene therapies. This segment also provides Cocoon platform, a closed automated system for patient-scale cell therapy manufacturing; and specialty raw materials and enabling technology solutions in cell and gene therapy, injectable drugs, vaccines, and bio-manufacturing markets. The Capsules & Health Ingredients segment offers capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical customers. Lonza Group AG was incorporated in 1897 and is headquartered in Basel, Switzerland.
help-icon Live chat